Molecular Engineering of Erythrotropic Bacteria for Treatment and Prevention of Human Malaria

Investigator: Joseph Derisi, PhD
Sponsor: Bill & Melinda Gates Foundation

Location(s): United States


Joseph DeRisi of the University of California at San Francisco proposes to engineer naturally occurring erythrotropic bacteria to target malaria infected red blood cells to serve as a potential prophylactic and treatment for malaria in humans.